Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
76.74
-0.82 (-1.06%)
At close: Dec 17, 2025, 4:00 PM EST
75.21
-1.53 (-1.99%)
After-hours: Dec 17, 2025, 7:29 PM EST
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $14.84 billion as of December 17, 2025. Its market cap has increased by 52.45% in one year.
Market Cap
14.84B
Enterprise Value
13.32B
1-Year Change
52.45%
Ranking
Category
Stock Price
$76.74
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $14.84B, an increase of 802.13%. That is a compound annual growth rate of 45.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 14.99B | 85.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.07B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |